Surgery Partners Q4 Adjusted EPS $0.44 Beats $0.38 Estimate, Sales $735.40M Miss $741.40M Estimate
Portfolio Pulse from Benzinga Newsdesk
Surgery Partners (NASDAQ:SGRY) reported Q4 adjusted EPS of $0.44, surpassing the $0.38 estimate, marking a 62.96% increase from last year. However, their sales of $735.40M fell short of the $741.40M estimate, a 4.00% increase from the previous year.
February 26, 2024 | 12:32 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Surgery Partners reported a Q4 adjusted EPS of $0.44, beating estimates, with a 62.96% YOY increase. Sales of $735.40M missed estimates but grew 4.00% YOY.
Beating EPS estimates with significant year-over-year growth indicates strong financial health and operational efficiency, likely leading to positive investor sentiment. However, the slight miss in sales estimates could temper some of the enthusiasm, but the overall positive earnings growth is expected to have a more significant impact on the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100